Barclays PLC Aquestive Therapeutics, Inc. Transaction History

Barclays PLC

$854 Billion
Q3 2025

A detailed history of Barclays PLC transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Barclays PLC holds 131,758 shares of AQST stock, worth $710,175. This represents 0.0% of its overall portfolio holdings.

Number of Shares

131,758

Previous 153,828 14.35%

Holding current value

$710,175

Previous $509,000 44.6%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	$3.4 - $5.99 $75,038 - $132,199	-22,070 Reduced 14.35%	131,758 $736,000
Q2 2025 Aug 13, 2025	BUY	$2.22 - $3.58 $157,333 - $253,718	70,871 Added 85.43%	153,828 $509,000
Q1 2025 May 15, 2025	SELL	$2.54 - $3.75 $90,815 - $134,077	-35,754 Reduced 30.12%	82,957 $241,000
Q4 2024 Feb 13, 2025	BUY	$3.46 - $5.64 $67,120 - $109,410	19,399 Added 19.53%	118,711 $422,000
Q3 2024 Nov 15, 2024	BUY	$2.4 - $5.09 $176,500 - $374,328	73,542 Added 285.38%	99,312 $495,000

Q2 2024 Aug 14, 2024	BUY	$2.31 - $4.5 $59,528 - $115,965	25,770 New	25,770 $67,000
Q3 2023 Nov 07, 2023	BUY	$1.5 - $2.24 $10,716 - $16,002	7,144 New	7,144 $11,000
Q2 2022 Aug 12, 2022	SELL	$0.64 - $2.57 $15,890 - $63,810	-24,829 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$3.69 - $6.37 $11,427 - $19,727	-3,097 Reduced 11.09%	24,829 $97,000
Q3 2021 Nov 09, 2021	SELL	$3.25 - $4.66 $11,232 - $16,104	-3,456 Reduced 11.01%	27,926 $122,000
Q2 2021 Aug 13, 2021	BUY	$3.29 - $5.21 $48,593 - $76,951	14,770 Added 88.91%	31,382 $125,000
Q1 2021 May 13, 2021	BUY	$4.17 - $6.73 $42,521 - $68,625	10,197 Added 158.96%	16,612 $86,000
Q4 2020 Feb 11, 2021	SELL	$4.65 - $7.79 $12,392 - $20,760	-2,665 Reduced 29.35%	6,415 $34,000
Q3 2020 Nov 12, 2020	SELL	$4.12 - $9.09 $95,839 - $211,451	-23,262 Reduced 71.93%	9,080 $43,000
Q2 2020 Aug 12, 2020	BUY	$1.84 - $6.44 $59,509 - $208,282	32,342 New	32,342 $156,000
Q1 2020 May 13, 2020	SELL	$1.54 - $6.75 $244 - $1,073	-159 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$3.06 - $8.78 $1,995 - $5,724	-652 Reduced 80.39%	159 $1,000
Q3 2019 Nov 14, 2019	BUY	$3.04 - $4.91 $1,188 - $1,919	391 Added 93.1%	811 $2,000
Q2 2019 Aug 14, 2019	SELL	$3.72 - $6.95 $20,240 - $37,814	-5,441 Reduced 92.83%	420 $2,000
Q1 2019 May 15, 2019	BUY	$5.74 - $8.05 $33,642 - $47,181	5,861 New	5,861 $40,000
Q4 2018 Feb 14, 2019	SELL	$6.09 - $18.0 $11,912 - $35,208	-1,956 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$15.0 - $18.96 $29,340 - $37,085	1,956 New	1,956 $34,000

Others Institutions Holding AQST

# of Institutions

163

Shares Held

65.9M

Call Options Held

794K

Put Options Held

457K

View Full List

About Aquestive Therapeutics, Inc.

Ticker AQST
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,350,700
Market Cap $288M
Description
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...

More about AQST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account